Japan-based Global Specialty Pharmaceutical Company Kyowa Kirin Co., Ltd. (President and CEO: Masashi Miyamoto.) (TOKYO:4151) today announced that Masashi Miyamoto, Ph.D. will take the role of ...

TOKYO--(BUSINESS WIRE)--Japan-based Global Specialty Pharmaceutical Company Kyowa Kirin Co., Ltd. (President and CEO: Masashi Miyamoto.) (TOKYO:4151) today announced that Masashi Miyamoto ...

Helping Kyowa Kirin transform into a true Japan-based global specialty pharmaceutical company that makes people smile has been one of the greatest privileges of my life, and I am confident that ...

31, 2024 /PRNewswire/ -- Japan-based Global Specialty Pharmaceutical Company Kyowa Kirin Co., Ltd. (President and CEO: Masashi Miyamoto) today announced that Masashi Miyamoto, Ph.D. will take the ...

Miyamoto, as Chairman and CEO, will lead discussions on Kyowa Kirin’s direction and overall strategy and maintain key relationships with stakeholders, while Mullick, as President and COO, will oversee ...

Changes designed to further deliver on company’s 2030 Vision and commitment to advancing novel treatments for Bone/Mineral, Intractable Hematological Diseases/Hemato-Oncology and Rare Diseases TOKYO, ...

A trusted, resilient global supply chain is a critical component of bringing products to life for your customers. In the face of increasing uncertainty and disruption in the world, our diverse supply ...

Airbus is planning to replace the head of its commercial aircraft business, and stick with its goal to deliver about 770 aircraft this year.